CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Why Membrane Matters In AAV Filtration

  Gene therapy is revolutionizing medicine to offer one-time treatments. Find out how AAV vectors are leading the way to optimize production and make these life-changing therapies accessible.

• A Risk-Based Approach To Plasmid DNA And mRNA Process Development

  Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.

• Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody

  Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

• Solve ATMP Aseptic Filling Challenges With Gloveless Isolators

  Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.

• The True ROI Of Decentralized Clinical Trials

  Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

• Form Fill And Seal Label Applicator For Drug Packaging

  Discover a solution that ensures particularly efficient and reliable vertical and horizontal form fill and seal machine labeling.

• An Adaptable, Intelligent Centerpiece For Customizable Manufacturing

  Data from a CAR T cell manufacturing case study challenges the assumption that automated cell processing platforms and third-party expansion technologies are inherently incompatible.

• Elevating mRNA Manufacturing Toward GMP-Readiness

  The mRNA Technology Transfer Program empowers LMICs with scalable vaccine production. Learn about a partnership that drives innovation in mRNA and sets a global blueprint for equitable health access.

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Enabling Market Access As CGTs Reach More Patients

  Bringing potentially curative cell and gene therapies to more patients requires a focused approach to market access. Discover essential insights into payer dynamics, pricing innovations, and treatment evolution.